Page last updated: 2024-10-28

ibuprofen and Carcinoma, Transitional Cell

ibuprofen has been researched along with Carcinoma, Transitional Cell in 1 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khwaja, F1
Allen, J1
Lynch, J1
Andrews, P1
Djakiew, D1

Other Studies

1 other study available for ibuprofen and Carcinoma, Transitional Cell

ArticleYear
Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein.
    Cancer research, 2004, Sep-01, Volume: 64, Issue:17

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Transitional Cell; Carrier Proteins; Cell Line,

2004